About Doug Dachille
Form D filings for Lyndra Therapeutics in 2023 list Doug Dachille as director.
Doug Dachille first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Doug Dachille in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Doug Dachille works with at each company, as listed on that company's latest Form D.
Lyndra Therapeutics, Inc. · Form D, Dec 29, 2023
ZA
Zafi Avnur
Director
AS
Ashish Singh
Director
JB
Jessica Ballinger
Chief Executive Officer and director
RL
Robert Langer
Director
AS
Amy Schulman
Director
PH
Patricia Hurter
Director
CR
Catherine Reynolds
Director
HM
Helene Madonick
Director
CT
Carlo Traverso
Director